Cocrystal Pharma, Inc. Reports Q1, Provides Updates on its Antiviral Development Programs and Milestones
- ByInvesting.com-
Cocrystal Pharma, Inc. (Nasdaq: COCP) reports financial results for the three months ended March 31, 2022, and provides updates on its antiviral pipeline, upcoming milestones and...